Irish medtech maker Mainstay Medical initiates an Australian clinical trial of its ReActiv8 neurostimulation implant in treatment of chronic low back pain.
Dublin-based Mainstay Medical touted the launch of a new clinical trial evaluating its ReActiv8 implantable neurostimulator at 3 clinical sites in Australia.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/O2bJfY
Cap comentari:
Publica un comentari a l'entrada